[조사자료] 글로벌 암 생검 시장 (2023-2030) : 액체 생검, 코어 바늘 생검

■ 영문 제목 : Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV061 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 140 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 암 생검 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 암 생검 시장 규모는 2030년까지 연평균 8. 04% 성장하여 516. 1억 달러에 달할 것으로 추정됩니다. 분자 의학의 발전은 암의 분자 특성 분석을 위한 새로운 장비의 개발을 촉진하고 있습니다. 그 결과, 액체 생검에 대한 수용과 승인 증가가 전체 시장 성장의 큰 원동력이 될 것으로 예상됩니다.

많은 신생 제조업체들이 내시경 기반 암 생검을 개선할 수 있는 장비 개발에 전념하고 있습니다. 예를 들어, 2023년 3월 스웨덴의 BiBBInstruments AB는 EndoDrill이라는 브랜드로 암 생검 장비 시장에서 확고한 입지를 구축했습니다. 이 회사는 기존 생검기구와 관련하여 암 환자의 신속하고 정확한 진단을 가능하게 하는 생검기구를 변경했습니다. 또한, 코어니들 및 연성 내시경 생검에 대응하는 생검기구를 제공하고 있습니다. 이러한 기업들의 시장 진입으로 암 생검 장비에 대한 접근성이 높아질 것으로 기대됩니다.

종양학에 기반한 유전체 데이터 분석과 맞춤의료 분야는 액체생검의 등장으로 유리한 전망이 예상됩니다. 규제 당국은 액체 생검이 가진 큰 잠재력으로 인해 이들 제품의 상용화를 적극적으로 지원하며 임상 현장에서의 활용을 촉진하고 있습니다. 액체 생검은 다양한 체액을 통해 암을 쉽게 검출할 수 있으며, 이 기술의 발전으로 진단용 암 생체 물질을 얻기 위한 매력적인 비침습적 접근법이 되고 있습니다.

액체 생검 분야는 바이오 의약품 제조 및 유전체 데이터 분석 관련 기업들의 대규모 투자와 전략적 노력으로 인해 향후 몇 년 동안 빠르게 성장할 것으로 예상됩니다. 스타트업들은 QIAGEN Bioinformatics, Fabric Genomics, Agilent Technologies, SOPHiA Genetics와 같은 기존 업계 참여 기업들과 파트너십을 맺으려는 움직임을 보이고 있습니다. 이러한 협업 추세는 전체 시장의 성장을 더욱 촉진할 것으로 예상됩니다.

암 생검 시장 보고서 주요 내용

- 2022년 제품별로는 키트 및 소모품이 가장 큰 시장 점유율을 차지할 것으로 예상되며, 이러한 우위는 예측 기간 동안 지속될 것으로 전망됩니다. 키트 및 소모품의 채택 증가의 배경에는 종양 생검에서 액체 생검으로의 뚜렷한 전환이 있습니다.

- 조직 생검은 여전히 생검 과정의 기본이며 다양한 진단 응용 분야에서 널리 사용되고 있습니다. 또한 종양 생검은 주로 개인 수준의 진단과 진행 중인 종양학 치료의 효과를 모니터링하는 데 사용됩니다.

- 용도별로는 유방암이 2022년 세계 시장을 장악하고 예측 기간 동안 선두를 유지할 것으로 예상됩니다. 개복 수술 생검은 이러한 병리의 진단에서 확립된 정확성으로 인해 의심스러운 유방 병변을 가진 환자를 평가하기 위한 기준으로 여전히 사용되고 있습니다. 결과적으로 이 부문의 수익은 유방 병변 진단에 대한 입증된 효과로 인해 강화되고 있습니다.

- 북미는 활동적인 조직과 암 재단이 집중되어 있어 2022년 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 미국의 정부 기관과 민간 암 재단의 강력한 네트워크는 이 지역의 수익 창출 능력에 크게 기여하고 있습니다.

- 주요 기업으로는 QIAGEN, ANGLE plc, Myriad Genetics, Danaher, F. Hoffmann-La Roche Ltd, Lucence Diagnostics Pte, BIOCEPT, INC. 등이 있습니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 세계의 암 생검 시장 변수, 동향 및 범위
Chapter 4. 세계의 암 생검 시장 : 제품별 분석
Chapter 5. 세계의 암 생검 시장 : 유형별 분석
Chapter 6. 세계의 암 생검 시장 : 용도별 분석
Chapter 7. 세계의 암 생검 시장 : 지역별 분석
Chapter 8. 세계의 암 생검 시장 : 경쟁 현황
Chapter 9. KOL 권고사항/애널리스트 시점

■ 보고서 목차

Table of Contents

Chapter 1 Cancer Biopsy Market: Research Methodology And Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Type Segment
1.1.1.3 Application Segment
1.1.1.4 End Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Cancer Biopsy Market: Executive Summary
2.1 Market Outlook
2.2 Product And Type Snapshot
2.3 Application Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Cancer Biopsy Market: Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Advent Of Liquid Biopsy
3.2.1.2 Transition Of Novel Oncology Diagnostics From Bench To Clinics
3.2.1.3 Advancements In Quality And Payment Pertaining To Genetic Cancer Tests
3.2.2 Market Restraint Analysis
3.2.2.1 Risks Associated With Biopsy Procedures
3.2.2.2 Technical And Clinical Challenges
3.3 Industry Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Pestel Analysis
Chapter 4 Cancer Biopsy Market: Product Business Analysis
4.1 Cancer Biopsy Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Kits And Consumabkes
4.3.1 Kits And Consumabels Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Services
4.4.1 Services Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Cancer Biopsy Market: Type Business Analysis
5.1 Cancer Biopsy Market: Type Movement Analysis
5.2 Tissue Biopsies
5.2.1 Tissue Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2 Needle Biopsies
5.2.2.1 Needle Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2.2 Fine Needle Aspiration (Fna)
5.2.2.2.1 Fine Needle Aspiration (Fna) Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2.3 Core Needle Biopsy (Cnb)
5.2.2.3.1 Core Needle Biopsy (Cnb) Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.3 Surgical Biopsies
5.2.3.1 Surgical Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Liquid Biopsies
5.3.1 Liquid Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Others
5.4.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Cancer Biopsy Market: Application Business Analysis
6.1 Cancer Biopsy Market: Application Movement Analysis
6.2 Breast Cancer
6.2.1 Breast Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Colorectal Cancer
6.3.1 Colorectal Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Cervical Cancers
6.4.1 Cervical Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Lung Cancers
6.5.1 Lung Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Prostate Cancers
6.6.1 Prostate Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Skin Cancers
6.7.1 Skin Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.8 Blood Cancers
6.8.1 Blood Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.9 Kidney Cancers
6.9.1 Kidney Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.10 Liver Cancers
6.10.1 Liver Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.11 Pancreatic Cancers
6.11.1 Pancreatic Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.12 Ovarian Cancers
6.12.1 Ovarian Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.13 Others
6.13.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Cancer Biopsy Market: Regional Business Analysis
7.1 Regional Market Snapshot
7.2 North America
7.2.1 North America Cancer Biopsy Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.2.2.2 Key Country Dynamics
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Canada Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.2.3.2 Key Country Dynamics
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.2 Uk
7.3.2.1 Uk Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.2.2 Key Country Dynamics
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Germany Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.3.2 Key Country Dynamics
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.4 Spain
7.3.4.1 Spain Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.4.2 Key Country Dynamics
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.5 France
7.3.5.1 France Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.5.2 Key Country Dynamics
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.6 Italy
7.3.6.1 Italy Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.6.2 Key Country Dynamics
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Denmark Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.7.2 Key Country Dynamics
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Sweden Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.8.2 Key Country Dynamics
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Norway Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.9.2 Key Country Dynamics
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.4 Asia Pacific
7.4.1 Asia-Pacific Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.2.2 Key Country Dynamics
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.3 China
7.4.3.1 China Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.3.2 Key Country Dynamics
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.4 India
7.4.4.1 India Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.4.2 Key Country Dynamics
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.5 South Korea
7.4.5.1 South Korea Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.5.2 Key Country Dynamics
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Thailand Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.6.2 Key Country Dynamics
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.7 Australia
7.4.7.1 Australia Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.7.2 Key Country Dynamics
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.5 Latin America
7.5.1 Latin America Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.2.2 Key Country Dynamics
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.3 Mexico
7.5.3.1 Mexico Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.3.2 Key Country Dynamics
7.5.3.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.4 Argentina
7.5.4.1 Argentina Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.4.2 Key Country Dynamics
7.5.4.3 Regulatory Framework
7.5.4.4 Reimbursement Scenario
7.6 MEA
7.6.1 MEA Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.2.2 Key Country Dynamics
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.3.2 Key Country Dynamics
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.4 Uae
7.6.4.1 Uae Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.4.2 Key Country Dynamics
7.6.4.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Kuwait Cancer Biopsy Market, 2018 – 2030 (USD MILLION)
7.6.5.2 Key Country Dynamics
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario
Chapter 8 Cancer Biopsy Market: Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New product launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 QIAGEN
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 ILLUMINA, INC.
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 ANGLE PLC
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 BD (BECTON, DICKINSON AND COMPANY)
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 MYRIAD GENETICS
8.4.5.1 Company overview
8.4.5.1.1 Counsyl, Inc.
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 HOLOGIC, INC.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.7 BIOCEPT, INC.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 THERMO FISHER SCIENTIFIC, INC.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
9.4.9 DANAHER
8.4.9.1 Company overview
8.4.9.2 Beckman Coulter, Inc
8.4.9.3 Radiometer Medical ApS
8.4.9.4 HemoCue AB
8.4.9.5 Financial performance
8.4.9.6 Product benchmarking
8.4.10 F. HOFFMANN-LA ROCHE LTD.
8.4.10.1 Company overview
8.4.10.2 FOUNDATION MEDICINE, INC.
8.4.10.3 Financial performance
8.4.10.4 Product benchmarking
8.4.11 LUCENCE DIAGNOSTICS PTE. LTD.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.11.4 Strategic initiatives
8.4.12 GRAIL, INC.
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 GUARDANT HEALTH
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
8.4.14 EXACT SCIENCES CORPORATION
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 FREENOME HOLDINGS, INC.
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
8.4.16 BIODESIX (INTEGRATED DIAGNOSTICS)
8.4.16.1 Company overview
8.4.16.2 Financial performance
8.4.16.3 Product benchmarking
8.4.16.4 Strategic initiatives
8.4.17 ONCIMMUNE
8.4.17.1 Company overview
8.4.17.2 Financial performance
8.4.17.3 Product benchmarking
8.4.17.4 Strategic initiatives
8.4.18 EPIGENOMICS AG.
8.4.18.1 Company overview
8.4.18.2 Financial performance
8.4.18.3 Product benchmarking
8.4.18.4 Strategic initiatives
8.4.19 HELIOHEALTH (LABORATORY FOR ADVANCED MEDICINE)
8.4.19.1 Company overview
8.4.19.2 Financial performance
8.4.19.3 Product benchmarking
8.4.19.4 Strategic initiatives
8.4.20 GENESYSTEMS, INC. (GENESYS BIOLABS)
8.4.20.1 Company overview
8.4.20.2 Financial performance
8.4.20.3 Product benchmarking
8.4.20.4 Strategic initiatives
8.4.21 CHRONIX BIOMEDICAL, INC.
8.4.21.1 Company overview
8.4.21.2 Financial performance
8.4.21.3 Product benchmarking
8.4.21.4 Strategic initiatives
8.4.22 PERSONAL GENOME DIAGNOSTICS INC.
8.4.22.1 Company overview
8.4.22.2 Financial performance
8.4.22.3 Product benchmarking
8.4.22.4 Strategic initiatives
8.4.23 NATERA, INC.
8.4.23.1 Company overview
8.4.23.2 Financial performance
8.4.23.3 Product benchmarking
8.4.23.4 Strategic initiatives
8.4.24 PERSONALIS INC.
8.4.16.1 Company overview
8.4.24.2 Financial performance
8.4.24.3 Product benchmarking
8.4.24.4 Strategic initiatives
Chapter 9 KOL Recommendations/Analyst Perspective

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 4 North America cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 5 North America cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 9 Canada cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 10 Canada cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 11 Canada cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 12 Europe cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 13 Europe cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 14 Europe cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 15 Germany cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 16 Germany cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 17 Germany cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 18 UK cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 19 UK cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 20 UK cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 21 France cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 22 France cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 23 France cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 24 Spain cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 25 Spain cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 26 Spain cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 27 Italy cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 28 Italy cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 29 Italy cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 30 Denmark cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 31 Denmark cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 34 Sweden cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 36 Norway cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 37 Norway cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 38 Norway cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 40 Asia Pacific cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 42 Japan cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 43 Japan cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 44 Japan cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 45 China cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 46 China cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 47 China cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 48 India cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 49 India cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 50 India cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 51 South Korea cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 52 South Korea cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 53 South Korea cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 54 Thailand cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 55 Thailand cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 56 Thailand cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 57 Australia cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 58 Australia cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 59 Australia cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 60 Latin America cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 61 Latin America cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 62 Latin America cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 63 Brazil cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 64 Brazil cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 65 Brazil cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 66 Mexico cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 67 Mexico cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 68 Mexico cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 69 Argentina cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 70 Argentina cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 71 Argentina cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 72 MEA cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 73 MEA cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 74 MEA cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 75 South Africa cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 76 South Africa cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 77 South Africa cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 81 UAE cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 82 UAE cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 83 UAE cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 84 Kuwait cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 85 Kuwait cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 86 Kuwait cancer biopsy market, by application, 2018 - 2030 (USD Million)

※본 조사보고서 [글로벌 암 생검 시장 (2023-2030) : 액체 생검, 코어 바늘 생검] (코드 : GRV23NOV061) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 암 생검 시장 (2023-2030) : 액체 생검, 코어 바늘 생검] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 잔디 깎기 시장 (2023~2030) : 수동, 전동, 가솔린, 로봇
GRV23MA095 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 잔디 깎기 시장 규모가 2023년부터 2030년 사이에 연평균 6.0% 성장하여, 2030년에는 485.9억 달러에 이를 것으로 예상하고 있습니다. 본 조사 보고서는 세계의 잔디 깎기 시장을...Lawn Mowers Market Growth & Trends The global lawn mowers market size is projected to reach USD 48.59 billion by 2030, registering a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The industry's growth saw a minor setback in 2020 due to supply shortages brought...

세계의 데이터 센터 전원 시장 (2023~2030) : UPS, PDU, 버스웨이
GRV23MR078 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 데이터 센터 전원 시장 규모가 2023년부터 2030년 사이에 CAGR 8.0% 증가하여, 2030년에는 150.1억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는...Data Center Power Market Growth & Trends The global data center power market size is expected to reach USD 15.01 billion by 2030, according to a new study by Grand View Research, Inc., exhibiting a CAGR of 8.0% during the forecast period. The shift in focus of end-users towards colocation...

세계의 원예 장비 시장 (2023~2030) : 잔디 깎기, 소형 전동 공구, 핸드 툴 및 바퀴 부착 기구, 급수 장치
GRV23MA094 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 원예 장비 시장 규모가 2023년부터 2030년 사이에 연평균 6.0% 성장하여, 2030년에는 1,388.9억 달러에 달할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 원예 장비 시장을...Gardening Equipment Market Growth & Trends The global gardening equipment market size is projected to reach USD 138.89 billion by 2030, registering a CAGR of 6.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. Factors such as an increase in the middle-class population, an...

세계의 웨어러블 기술 시장 (2023~2030) : 헤드 및 아이 웨어, 리스트 웨어
GRV23MA100 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 웨어러블 기술 시장 규모가 2023년부터 2030년 사이에 연평균 14.6% 성장하여, 2030년에는 1861.4억 달러에 이를 것으로 예측하고 있습니다. 본 조사 자료는 세계의 웨어러블 기술 시장을...Wearable Technology Market Growth & Trends The global wearable technology market size is expected to reach USD 186.14 billion by 2030, expanding at a CAGR of 14.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. Due to its numerous functions in the healthcare, consumer...

글로벌 기관지 생검 기기 시장 (2023-2030) : 생검 겸자, 기관지내 바늘 흡인 (TBNA) 바늘, 세포학 브러쉬
GRV23NOV060 / Grand View Research / 2023년 9월 / 글로벌 기관지 생검 기기 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 기관지 생검 기기 시장 규모는 2023년부터 2030년까지 연평균 7. 2%의 성장률을 기록하여 2030년에는 972. 43백만...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 기관지 생검 기기 시장 변수/동향/범위 Chapter 4. 세계의 기관지 생검 기기 시장 : 제품별 예측 및 동향 분석 Chapter 5. 세계의 기관지 생검 기기 시장 : 지역별 예측 및 동향 분석 Chapter 6. 세계의 기관지 생검 기기 시장...